Update and status of Karessa Pharma's project K-03
Karessa Pharma Holding AB is working actively to operate the most advanced project, K-03 Vardenafil buccal film, through its various development phases as effectively as possible.Status project K-03 Vardenafil buccal film Karessa submitted an application for a clinical trial with K-03 Vardenafil buccal film to the Medical Products Agency on 31stof August, which the market has previously been informed of. The company has received questions from the Medical Products Agency that has been answered and an approval is expected to arrive in late October. The project is proceeding according to